Location History:
- South Plainfield, NJ (US) (2003)
- Plainfield, NJ (US) (2008)
Company Filing History:
Years Active: 2003-2008
Title: The Innovations of Howard C H Kuo
Introduction
Howard C H Kuo is a notable inventor based in Plainfield, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of sodium channel blockers and novel nodulosporic acid derivatives. With a total of two patents to his name, Kuo's work has the potential to impact various medical treatments.
Latest Patents
Kuo's latest patents include "Aryl-link-aryl substituted thiazolidine-dione and oxazolidine-dione as sodium channel blockers." This invention focuses on pharmaceutical compositions that incorporate effective amounts of these compounds to treat conditions such as acute pain, chronic pain, inflammatory pain, and several neurological disorders. His second patent, "C1 to C4 side chain modified nodulisporic acid analogs," relates to novel derivatives that serve as acaricidal, antiparasitic, insecticidal, and anthelmintic agents.
Career Highlights
Kuo is currently associated with Merck & Company, Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing effective treatments for complex medical conditions.
Collaborations
Kuo has collaborated with notable colleagues such as Prasun K Chakravarty and Peter T Meinke, contributing to the advancement of pharmaceutical research and development.
Conclusion
Howard C H Kuo's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.